Emisphere Technologies, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Emisphere Technologies, Inc.
Nestle-backed Amazentis says clinical studies show its Timeline Cellular Nutrition delivers “significant” improvement in muscle strength after four months and delivers six times more urolithin A than pomegranate juice. Direct-to-consumer sales currently are available only in the US.
Swiss confections, food and nutritional products giant launches Nestlé Cerevita Instant Sour Porridge as affordable nutrition for consumers in Southeast Africa. With micronutrients often lacking in consumers’ diets there, it was developed in about one year by scientists at Nestlé's R&D center in Côte d'Ivoire.
The big biotech will pay $300m to acquire a 49.9% equity interest in the cancer immunotherapy startup with a buyout option. It is one of several immune checkpoints Gilead has secured access to this year.
Executives from Moderna, Pfizer and AstraZeneca and others will give politicians in Washington DC an update on the progress of their vaccine - but will resist pressure to make promises of a breakthrough in 2020.
- OTC, Consumer
- Large Molecule
- Other Names / Subsidiaries
- Clinical Technologies Associates, Inc.